Adjuvant chemotherapy for stage III colon cancer: relative dose intensity and survival among veterans


Given the paucity of information on dose intensity, the objective of this study is to describe the use of adjuvant chemotherapy for stage III colon cancer, focusing on relative dose intensity (RDI), overall survival (OS) and disease-free survival (DFS). Retrospective cohort of 367 patients diagnosed with stage III colon cancer in 2003–2008 and treated at 19… (More)
DOI: 10.1186/s12885-015-1038-y


8 Figures and Tables